n-benzyladriamycin-14-valerate and Cardiomyopathies, Primary

n-benzyladriamycin-14-valerate has been researched along with Cardiomyopathies, Primary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, C; Hofmann, PA; Lothstein, L; Morrison, RR	1

Other Studies

1 other study(ies) available for n-benzyladriamycin-14-valerate and Cardiomyopathies, Primary

Article	Year
Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198). The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:1 Topics: AMP-Activated Protein Kinase Kinases; Animals; Antibiotics, Antineoplastic; Blotting, Western; Calcium; Cardiomyopathies; Cardiotonic Agents; Doxorubicin; Electrophoresis, Polyacrylamide Gel; Indicators and Reagents; Male; Mass Spectrometry; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Phosphorylation; Poly Adenosine Diphosphate Ribose; Protein Kinase C-epsilon; Protein Kinases; Rats; Rats, Wistar	2010

Article

Year

Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198).

The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:1

Topics: AMP-Activated Protein Kinase Kinases; Animals; Antibiotics, Antineoplastic; Blotting, Western; Calcium; Cardiomyopathies; Cardiotonic Agents; Doxorubicin; Electrophoresis, Polyacrylamide Gel; Indicators and Reagents; Male; Mass Spectrometry; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Phosphorylation; Poly Adenosine Diphosphate Ribose; Protein Kinase C-epsilon; Protein Kinases; Rats; Rats, Wistar

2010